SCHEMBL6173451

SCHEMBL6173451

CNC(=O)C(c1ccnc(-c2ccc(Cl)cc2)c1)N1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 7/20 0.41
CYP2C9 P11712 1/20 0.35
TRPV3 Q8NET8 4/20 0.33
TRPV1 Q8NER1 2/20 0.33
CNR1 P21554 2/20 0.33
XIAP P98170 1/20 0.32
BIRC2 Q13490 1/20 0.32
THRB P10828 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171970 0.91 IGF1R (0.41) IGF1RCYP2C9TRPV3THRBMAPT
SCHEMBL6173179 0.87 IGF1R (0.49) IGF1RXIAPBIRC2
SCHEMBL6177675 0.79 SCN10A (0.41) IGF1RCYP2C9
SCHEMBL2941543 0.76 IGF1R (0.58) IGF1R
SCHEMBL6175911 0.74 THRB (0.38) IGF1RCYP2C9TRPV3CNR1THRB
SCHEMBL6172653 0.72 IGF1R (0.38) IGF1RXIAPBIRC2
SCHEMBL6173805 0.71 IGF1R (0.36) IGF1RTRPV3CNR1THRB
SCHEMBL2942002 0.71 IGF1R (0.45) IGF1R
SCHEMBL6173800 0.69 ITGAL (0.42) IGF1RCYP2C9TRPV3THRBMAPT
SCHEMBL6171982 0.69 IGF1R (0.41) IGF1RCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed